Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for AZLGF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for AZLGF and 80,000+ other tickers.
See exactly how AZLGF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for AZLGF and 80,000+ other tickers.
Azelis Group NV is a global distributor of specialized chemical products and food components, with operations extending from its home base in Belgium to international markets. The company provides materials for a wide array of sectors. Its life sciences division supports personal care, pharmaceuticals, food and nutrition, specialized agricultural and horticultural needs, and both household and industrial chemical applications. Within the broader industrial chemicals industry, Azelis supplies solutions for coatings, adhesives, sealants, and elastomers (CASE), additives for rubber and plastics…
ANTWERP, Belgium--(BUSINESS WIRE)--Regulatory News: Azelis Group NV (Brussels:AZE): Highlights Q1 2026 Revenue of EUR 1.0bn, down 0.7% year-on-year in constant currency (-5.2% reported), reflecting a 3.9% organic decline, offset by a 3.3% contribution from acquisitions. Organic performance was underpinned by a solid 4% growth in APAC and broadly stable trends in the Americas, offset by weaker conditions in EMEA. Gross profit of EUR 246m resulting in gross profit margin of 23.7%. The 38 bp gross.
Azelis Group NV (AZLGY) Q4 2025 Earnings Call Transcript
Azelis remains a robust free cash flow generator despite sector-wide margin pressure and modest revenue declines. AZE trades at a double-digit free cash flow yield, with non-cash amortization weighing on reported earnings but not on cash generation. Management prioritizes M&A over dividends, leveraging sector weakness to pursue bolt-on acquisitions and enhance long-term value.
Azelis Group NV (OTCMKTS:AZLGF - Get Free Report) was down 15.7% during mid-day trading on Monday. The stock traded as low as C$10.28 and last traded at C$10.28. Approximately 7,095 shares traded hands during mid-day trading, an increase of 6% from the average daily volume of 6,700 shares. The stock had previously closed at
IMCD (IMCDY) and Azelis (AZLGF) are leading, capital-light specialty chemical distributors poised for 20%+ annual returns over 5-10 years. Both benefit from industry consolidation, growing scale, exclusive supplier relationships, and strong integration of acquisitions, supporting steady organic and inorganic growth. IMCD stands out with a cleaner balance sheet, longer public track record, and greater APAC exposure, offering a superior risk-adjusted return profile.